Description
Vegfxta 100mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient is believed to be Bevacizumab, a recombinant humanized monoclonal antibody. Bevacizumab works by inhibiting vascular endothelial growth factor (VEGF), a protein that promotes the growth of new blood vessels. By blocking VEGF, Vegfxta helps to starve tumors of their blood supply, thereby slowing or stopping their growth. It is indicated for the treatment of specific metastatic cancers, often in combination with chemotherapy. The dosage and administration of Vegfxta 100mg Injection should be determined by a qualified healthcare professional based on the patient’s condition and response to treatment. Common side effects may include high blood pressure, proteinuria, nosebleeds, and fatigue. Serious side effects can occur, and patients should be closely monitored. Vegfxta 100mg Injection should be stored at room temperature and protected from light. It is crucial to consult with a doctor for proper diagnosis, treatment, and management of any side effects.
